Literature DB >> 6681739

Diurnal variation in prednisolone kinetics.

J English, M Dunne, V Marks.   

Abstract

Plasma concentrations of free and total prednisolone were measured after oral doses at four time points to investigate the possibility of a diurnal variation in the drug's kinetics. There were marked differences in plasma prednisolone concentrations, clearance rates, and bioavailability of both free and total fractions at different times of the day. Changes in the protein binding characteristics of prednisolone with clock time resulted in marked differences between the kinetics of free and total prednisolone. It is recommended that for maximum efficacy and minimum toxicity prednisolone therapy be confined to once-daily dosing in the morning.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6681739     DOI: 10.1038/clpt.1983.49

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  8 in total

Review 1.  Therapeutic drug monitoring in the neonate and paediatric age group. Problems and clinical pharmacokinetic implications.

Authors:  J T Gilman
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of prednisone and prednisolone.

Authors:  B M Frey; F J Frey
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

3.  Comparative study of availability of prednisolone after intestinal infusion of prednisolone metasulfobenzoate and prednisone.

Authors:  C Rollin; O Chosidow; B Diquet; C Dutreuil; S Herson; J Revuz; J C Delchier
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

4.  Cortisol does not inhibit prednisolone clearance.

Authors:  P J Meffin; B C Sallustio; Y J Purdie; R A Robson; L M Wing; P M Brooks
Journal:  Br J Clin Pharmacol       Date:  1985-10       Impact factor: 4.335

5.  Prednisolone protein binding in renal transplant patients.

Authors:  P A Reece; A P Disney; I Stafford; J C Shastry
Journal:  Br J Clin Pharmacol       Date:  1985-08       Impact factor: 4.335

6.  Alterations in prednisolone disposition as a result of time of administration, gender and dose.

Authors:  P J Meffin; P M Brooks; B C Sallustio
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

7.  Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 am versus 4 pm.

Authors:  L E Fisher; E A Ludwig; J A Wald; R R Sloan; E Middleton; W J Jusko
Journal:  Clin Pharmacol Ther       Date:  1992-06       Impact factor: 6.875

Review 8.  Clinical pharmacokinetics in organ transplant patients.

Authors:  R Venkataramanan; K Habucky; G J Burckart; R J Ptachcinski
Journal:  Clin Pharmacokinet       Date:  1989-03       Impact factor: 6.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.